Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease

Clinical trial NCT01862536 · COMPLETED

Trial details

NCT number: NCT01862536
Sponsor: VA Office of Research and Development
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Hypertension Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2013-10-01
Primary completion: 2019-08-31
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.